Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larissa Lisnevskaia

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|August 27, 2013
Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatmentGrainne Murphy, Larissa Lisnevskaia, David Isenberg
Lancet (London, England)|June 3, 2014
Systemic lupus erythematosusLarissa Lisnevskaia, Grainne Murphy, David Isenberg
Rheumatology and Therapy|March 12, 2024
Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP StudyLouis Bessette, Jonathan Chan, Andrew Chow, et al.
Arthritis Research & Therapy|March 2, 2017
Presence of an interferon signature in individuals who are anti-nuclear antibody positive lacking a systemic autoimmune rheumatic disease diagnosisJoan Wither, Sindhu R Johnson, Tony Liu, et al.
Arthritis Research & Therapy|November 6, 2019
Fatigue severity in anti-nuclear antibody-positive individuals does not correlate with pro-inflammatory cytokine levels or predict imminent progression to symptomatic diseaseWaleed Hafiz, Rawad Nori, Ariana Bregasi, et al.
Arthritis Care & Research|June 9, 2022
Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational StudyBoulos Haraoui, Majed Khraishi, Denis Choquette, et al.
Arthritis Research & Therapy|November 30, 2018
The presence of anti-nuclear antibodies alone is associated with changes in B cell activation and T follicular helper cells similar to those in systemic autoimmune rheumatic diseaseYuriy Baglaenko, Nan-Hua Chang, Sindhu R Johnson, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|August 27, 2013
Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatmentGrainne Murphy, Larissa Lisnevskaia, David Isenberg
Lancet (London, England)|June 3, 2014
Systemic lupus erythematosusLarissa Lisnevskaia, Grainne Murphy, David Isenberg
Rheumatology and Therapy|March 12, 2024
Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP StudyLouis Bessette, Jonathan Chan, Andrew Chow, et al.
Arthritis Research & Therapy|March 2, 2017
Presence of an interferon signature in individuals who are anti-nuclear antibody positive lacking a systemic autoimmune rheumatic disease diagnosisJoan Wither, Sindhu R Johnson, Tony Liu, et al.
Arthritis Research & Therapy|November 6, 2019
Fatigue severity in anti-nuclear antibody-positive individuals does not correlate with pro-inflammatory cytokine levels or predict imminent progression to symptomatic diseaseWaleed Hafiz, Rawad Nori, Ariana Bregasi, et al.
Arthritis Care & Research|June 9, 2022
Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational StudyBoulos Haraoui, Majed Khraishi, Denis Choquette, et al.
Arthritis Research & Therapy|November 30, 2018
The presence of anti-nuclear antibodies alone is associated with changes in B cell activation and T follicular helper cells similar to those in systemic autoimmune rheumatic diseaseYuriy Baglaenko, Nan-Hua Chang, Sindhu R Johnson, et al.
Pageof 1